# /controllers/protocol.py
from fastapi import HTTPException
import uuid
import time
from typing import Dict, Any, List, Optional

from trialsage.models.schemas import ProtocolRequest, ContinueRequest, EvidenceQuery


def get_protocol_suggestions(req: ProtocolRequest) -> Dict[str, Any]:
    """
    Generate protocol suggestions for a specific indication
    
    Args:
        req: A ProtocolRequest containing indication details and preferences
        
    Returns:
        dict: Contains protocol recommendations and evidence
    """
    try:
        # In production, would call OpenAI or similar for intelligent suggestions
        
        # Generate a thread ID if one wasn't provided
        thread_id = req.thread_id or f"thread_{uuid.uuid4().hex[:8]}"
        
        # Build a protocol suggestion structure
        protocol_suggestion = {
            "thread_id": thread_id,
            "timestamp": int(time.time()),
            "indication": req.indication,
            "phase": req.phase or "Phase II",
            "summary": f"Protocol suggestion for {req.indication} {req.phase or 'study'}",
            "introduction": {
                "background": f"This protocol addresses the need for clinical evaluation of novel treatments for {req.indication}.",
                "rationale": "The study design is based on recent regulatory guidance and statistical best practices."
            },
            "design": {
                "type": "Randomized, double-blind, placebo-controlled study",
                "duration_weeks": req.duration_weeks or 24,
                "sample_size": req.sample_size or 120,
                "arms": [
                    {"name": "Treatment arm", "description": "Active treatment group", "size_percent": 50},
                    {"name": "Control arm", "description": "Placebo control", "size_percent": 50}
                ],
                "randomization": "1:1 randomization with stratification by baseline disease severity"
            },
            "population": {
                "inclusion_criteria": [
                    f"Adult patients with confirmed diagnosis of {req.indication}",
                    "Age 18-75 years",
                    "Able to provide informed consent"
                ],
                "exclusion_criteria": [
                    "Pregnancy or breastfeeding",
                    "Participation in another clinical trial within 30 days",
                    "History of hypersensitivity to the study medication"
                ]
            },
            "endpoints": {
                "primary": req.primary_endpoint or "Change from baseline in disease activity score at Week 12",
                "secondary": [
                    "Safety and tolerability",
                    "Change from baseline in quality of life measures",
                    "Proportion of patients achieving clinical response"
                ]
            },
            "statistical_considerations": {
                "power": 0.90,
                "alpha": 0.05,
                "analysis_population": "Intent-to-treat (ITT)",
                "handling_missing_data": "Multiple imputation"
            },
            "safety": {
                "assessments": [
                    "Adverse event monitoring",
                    "Laboratory safety tests",
                    "Vital signs"
                ],
                "stopping_rules": "The study will be stopped if safety concerns arise that outweigh potential benefits."
            },
            "supporting_evidence": [
                {
                    "source": "Clinical Study Report 12345",
                    "citation": "Smith et al. (2023)",
                    "relevance": "Similar study design with positive outcomes",
                    "strength": "High"
                },
                {
                    "source": "Regulatory Guidance",
                    "citation": "FDA Guidance for Industry (2022)",
                    "relevance": "Recent regulatory recommendations",
                    "strength": "High"
                }
            ],
            "regulatory_considerations": {
                "ind_requirements": "Standard IND submission with 30-day review period",
                "special_populations": "Optional cohort expansion for elderly patients may be considered"
            }
        }
        
        return {
            "protocol": protocol_suggestion,
            "thread_id": thread_id,
            "success": True,
            "message": "Protocol suggestions generated successfully."
        }
    except Exception as e:
        raise HTTPException(status_code=500, detail=f"Error generating protocol suggestions: {str(e)}")


def continue_study_workflow(req: ContinueRequest) -> Dict[str, Any]:
    """
    Continue a study workflow with a specific thread and section
    
    Args:
        req: A ContinueRequest containing thread_id, study_id, section, and context
        
    Returns:
        dict: Contains updated protocol information for the requested section
    """
    try:
        # In production, would retrieve existing thread context and call AI service
        
        if not req.thread_id:
            raise ValueError("Thread ID is required")
            
        # Mock response based on requested section
        section_data = {}
        
        if req.section == "ind":
            section_data = {
                "title": "IND Application Components",
                "components": [
                    {
                        "name": "Form FDA 1571",
                        "description": "Investigation New Drug Application Cover Sheet",
                        "status": "Required",
                        "notes": "Must be signed by sponsor"
                    },
                    {
                        "name": "Table of Contents",
                        "description": "Comprehensive listing of all items submitted",
                        "status": "Required",
                        "notes": "Follow standard CTD format"
                    },
                    {
                        "name": "Introductory Statement",
                        "description": "Brief description of the investigational drug",
                        "status": "Required",
                        "notes": "Include proposed indication and phase of study"
                    },
                    {
                        "name": "General Investigational Plan",
                        "description": "Overview of planned clinical investigations",
                        "status": "Required",
                        "notes": "Include estimated duration and number of subjects"
                    },
                    {
                        "name": "Investigator's Brochure",
                        "description": "Information about the investigational drug",
                        "status": "Required",
                        "notes": "Must be comprehensive and up-to-date"
                    },
                    {
                        "name": "Clinical Protocol",
                        "description": "Detailed study design and procedures",
                        "status": "Required",
                        "notes": "Must include safety monitoring plan"
                    },
                    {
                        "name": "Chemistry, Manufacturing, and Control (CMC) Information",
                        "description": "Information on drug composition and manufacturing",
                        "status": "Required",
                        "notes": "Must include stability data and certificate of analysis"
                    },
                    {
                        "name": "Pharmacology and Toxicology Information",
                        "description": "Non-clinical study results",
                        "status": "Required",
                        "notes": "Must include adequate animal testing data"
                    },
                    {
                        "name": "Previous Human Experience",
                        "description": "Information from prior clinical use",
                        "status": "Required if available",
                        "notes": "Include any existing clinical data"
                    }
                ],
                "timeline": {
                    "submission_prep": "4-6 weeks",
                    "fda_review": "30 days",
                    "total_estimated": "2-3 months"
                },
                "key_considerations": [
                    "Ensure all sections are complete and internally consistent",
                    "Provide clear justification for the proposed dose selection",
                    "Include comprehensive safety monitoring plan",
                    "Address any specific concerns from pre-IND interactions with FDA",
                    "Ensure protocol is designed to meet both research objectives and regulatory requirements"
                ]
            }
        elif req.section == "sap":
            section_data = {
                "title": "Statistical Analysis Plan",
                "overview": "This Statistical Analysis Plan (SAP) provides details of the statistical analyses that will be conducted for the clinical study.",
                "sections": [
                    {
                        "name": "Study Objectives",
                        "content": "Detailed primary and secondary objectives aligned with protocol endpoints"
                    },
                    {
                        "name": "Study Design",
                        "content": "Brief description of study design, including treatment arms and visit schedule"
                    },
                    {
                        "name": "Sample Size Determination",
                        "content": "Justification for the sample size based on power calculations"
                    },
                    {
                        "name": "Analysis Populations",
                        "content": "Definitions of Intent-to-Treat (ITT), Modified Intent-to-Treat (mITT), Per Protocol (PP), and Safety populations"
                    },
                    {
                        "name": "Primary Endpoint Analysis",
                        "content": "Detailed statistical methodology for analyzing the primary endpoint, including handling of missing data"
                    },
                    {
                        "name": "Secondary Endpoint Analyses",
                        "content": "Statistical approaches for each secondary endpoint with multiplicity adjustments if applicable"
                    },
                    {
                        "name": "Safety Analyses",
                        "content": "Methods for summarizing adverse events, laboratory data, and other safety parameters"
                    },
                    {
                        "name": "Interim Analyses",
                        "content": "Plans for any interim analyses and stopping rules if applicable"
                    },
                    {
                        "name": "Subgroup Analyses",
                        "content": "Pre-specified subgroups of interest for efficacy and safety analyses"
                    },
                    {
                        "name": "Handling of Missing Data",
                        "content": "Detailed approach for handling missing data, including sensitivity analyses"
                    }
                ],
                "statistical_methods": [
                    {
                        "test": "Mixed Model for Repeated Measures (MMRM)",
                        "application": "Primary efficacy analysis for continuous endpoints with repeated measurements",
                        "justification": "Accounts for within-subject correlation and handles missing data under MAR assumption"
                    },
                    {
                        "test": "Logistic Regression",
                        "application": "Analysis of binary endpoints",
                        "justification": "Allows adjustment for covariates"
                    },
                    {
                        "test": "Kaplan-Meier Estimator",
                        "application": "Time-to-event analyses",
                        "justification": "Standard approach for censored time-to-event data"
                    },
                    {
                        "test": "Cox Proportional Hazards Model",
                        "application": "Multivariate time-to-event analyses",
                        "justification": "Allows assessment of multiple predictors on survival outcomes"
                    }
                ],
                "multiplicity_strategy": "Hierarchical testing procedure for key secondary endpoints to control Type I error rate",
                "randomization_details": "Permuted block randomization with stratification factors"
            }
        elif req.section == "risk":
            section_data = {
                "title": "Risk Assessment and Mitigation Strategy",
                "risk_categories": [
                    {
                        "category": "Scientific/Study Design Risks",
                        "risks": [
                            {
                                "name": "Inadequate sample size",
                                "likelihood": "Medium",
                                "impact": "High",
                                "mitigation": "Conduct rigorous power calculations with sensitivity analyses"
                            },
                            {
                                "name": "Inappropriate endpoint selection",
                                "likelihood": "Medium",
                                "impact": "High",
                                "mitigation": "Review regulatory precedents and consult with KOLs"
                            },
                            {
                                "name": "High dropout rate",
                                "likelihood": "Medium",
                                "impact": "Medium",
                                "mitigation": "Implement retention strategies and plan for higher enrollment"
                            }
                        ]
                    },
                    {
                        "category": "Operational Risks",
                        "risks": [
                            {
                                "name": "Slow recruitment",
                                "likelihood": "High",
                                "impact": "High",
                                "mitigation": "Diversify recruitment sites and implement flexible recruitment strategies"
                            },
                            {
                                "name": "Data quality issues",
                                "likelihood": "Medium",
                                "impact": "High",
                                "mitigation": "Implement robust data monitoring plan and site training"
                            },
                            {
                                "name": "Supply chain disruptions",
                                "likelihood": "Medium",
                                "impact": "High",
                                "mitigation": "Maintain adequate buffer stock and backup vendors"
                            }
                        ]
                    },
                    {
                        "category": "Safety Risks",
                        "risks": [
                            {
                                "name": "Serious adverse events",
                                "likelihood": "Low",
                                "impact": "High",
                                "mitigation": "Implement rigorous safety monitoring and stopping rules"
                            },
                            {
                                "name": "Drug-drug interactions",
                                "likelihood": "Medium",
                                "impact": "Medium",
                                "mitigation": "Clear exclusion criteria and medication review process"
                            }
                        ]
                    },
                    {
                        "category": "Regulatory Risks",
                        "risks": [
                            {
                                "name": "IND rejection/clinical hold",
                                "likelihood": "Low",
                                "impact": "High",
                                "mitigation": "Pre-IND consultation with FDA and thorough application review"
                            },
                            {
                                "name": "Protocol amendments",
                                "likelihood": "Medium",
                                "impact": "Medium",
                                "mitigation": "Thorough protocol review and anticipation of potential issues"
                            }
                        ]
                    }
                ],
                "risk_summary": {
                    "high_priority_risks": 3,
                    "medium_priority_risks": 5,
                    "low_priority_risks": 1,
                    "overall_risk_level": "Medium"
                },
                "monitoring_plan": {
                    "safety_monitoring": "Independent Data Monitoring Committee (IDMC) with regular safety reviews",
                    "recruitment_monitoring": "Weekly tracking and monthly stakeholder reviews",
                    "data_quality_monitoring": "Risk-based monitoring approach with remote data review"
                }
            }
        else:
            section_data = {
                "title": f"Section: {req.section}",
                "message": "Section content not implemented yet."
            }
            
        return {
            "thread_id": req.thread_id,
            "section": req.section,
            "data": section_data,
            "success": True,
            "message": f"Continued workflow for section: {req.section}"
        }
    except Exception as e:
        raise HTTPException(status_code=500, detail=f"Error continuing study workflow: {str(e)}")


def get_supporting_evidence(req: EvidenceQuery) -> Dict[str, List[Dict[str, str]]]:
    """
    Retrieve supporting evidence for a specific topic
    
    Args:
        req: An EvidenceQuery containing the topic and optional filters
        
    Returns:
        dict: Contains evidence items with sources and quotes
    """
    try:
        # In production, would search vector database or call evidence retrieval service
        
        # Mock evidence response
        evidence_items = [
            {
                "source": "Smith et al. (2022). Journal of Clinical Research",
                "title": "Efficacy and Safety of Novel Treatments in Advanced Disease",
                "relevance_score": 0.92,
                "quote": "The study demonstrated a significant improvement in primary endpoints with an acceptable safety profile.",
                "study_design": "Randomized, double-blind, placebo-controlled study",
                "publication_date": "2022-03-15",
                "indication": req.indication or "Multiple indications",
                "phase": req.phase or "Phase III"
            },
            {
                "source": "FDA Guidance for Industry (2023)",
                "title": "Clinical Trial Design Considerations for Rare Diseases",
                "relevance_score": 0.87,
                "quote": "For rare diseases, innovative trial designs with adaptive elements may provide valuable solutions to common challenges.",
                "study_design": "Regulatory guidance",
                "publication_date": "2023-01-10",
                "indication": "Multiple rare diseases",
                "phase": "All phases"
            },
            {
                "source": "Johnson et al. (2021). Clinical Trials Journal",
                "title": "Statistical Considerations for Endpoint Selection",
                "relevance_score": 0.85,
                "quote": "Endpoint selection should balance regulatory requirements, statistical powering, and clinical meaningfulness.",
                "study_design": "Methodological review",
                "publication_date": "2021-11-05",
                "indication": "Multiple indications",
                "phase": "All phases"
            },
            {
                "source": "EMA Reflection Paper (2022)",
                "title": "Use of Patient-Reported Outcomes in Clinical Trials",
                "relevance_score": 0.82,
                "quote": "Patient-reported outcomes can provide valuable insights into treatment effects that may not be captured by traditional clinical measures.",
                "study_design": "Regulatory guidance",
                "publication_date": "2022-07-22",
                "indication": "Multiple indications",
                "phase": "All phases"
            },
            {
                "source": "Lee et al. (2023). Translational Research",
                "title": f"Novel Biomarkers for {req.indication or 'Disease'} Progression",
                "relevance_score": 0.80,
                "quote": "The identified biomarkers demonstrated strong correlation with disease progression and treatment response.",
                "study_design": "Prospective biomarker study",
                "publication_date": "2023-02-18",
                "indication": req.indication or "Multiple indications",
                "phase": req.phase or "Phase II"
            }
        ]
        
        # Filter by indication and phase if provided
        if req.indication:
            evidence_items = [item for item in evidence_items 
                             if req.indication.lower() in item['indication'].lower()]
                             
        if req.phase:
            evidence_items = [item for item in evidence_items 
                             if req.phase.lower() in item['phase'].lower()]
        
        # Apply limit
        evidence_items = evidence_items[:req.limit]
        
        return {
            "topic": req.topic,
            "thread_id": req.thread_id,
            "evidence": evidence_items,
            "success": True,
            "message": f"Found {len(evidence_items)} evidence items for topic: {req.topic}"
        }
    except Exception as e:
        raise HTTPException(status_code=500, detail=f"Error retrieving supporting evidence: {str(e)}")